<bill session="118" type="hr" number="836" updated="2024-07-24T15:20:01Z">
  <state datetime="2023-11-01">REFERRED</state>
  <status>
    <introduced datetime="2023-11-01"/>
  </status>
  <introduced datetime="2023-11-01"/>
  <titles>
    <title type="display">Urging the United States Government to enhance the Middle East region's capacity to dismantle and disrupt the illicit production and trafficking of the amphetamine-type stimulant also known as captagon, including the production of precursor chemicals.</title>
    <title type="official" as="introduced">Urging the United States Government to enhance the Middle East region's capacity to dismantle and disrupt the illicit production and trafficking of the amphetamine-type stimulant also known as captagon, including the production of precursor chemicals.</title>
  </titles>
  <sponsor bioguide_id="M001217"/>
  <cosponsors>
    <cosponsor bioguide_id="M001216" joined="2023-11-01"/>
  </cosponsors>
  <actions>
    <action datetime="2023-11-01">
      <text>Introduced in House</text>
    </action>
    <action datetime="2023-11-01" state="REFERRED">
      <text>Referred to the House Committee on Foreign Affairs.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSFA" name="House Foreign Affairs" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="International affairs"/>
  </subjects>
  <amendments/>
  <summary date="2023-12-07T23:50:15Z" status="Introduced in House">This resolution states that the illicit production of and trafficking of captagon, an amphetamine-type stimulant, is a growing problem in the Middle East, and that the United States should broaden its counternarcotics efforts in the region, including efforts targeting captagon.

The resolution also states the United States should condemn any use of captagon to enhance militant capabilities during the October 7, 2023, attacks in Israel.</summary>
</bill>
